CCND1 and breast carcinoma: With standardised methods and cut offs for the detection of <i>CCND1</i> amplification, <i>CCND1</i> amplification would have potential as a predictive biomarker in breast cancer patients.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/prospero/, identifier CRD42020208179.